Business Context and Reporting Period
This Form 8-K filing by Advanced Micro Devices, Inc. (AMD) is dated December 26, 2014. The report addresses Item 5.02 regarding the compensatory arrangements of Dr. Lisa Su, who was promoted to President and Chief Executive Officer in October 2014. The filing details the Board's response to a stockholder derivative action alleging that equity awards granted to Dr. Su in 2014 exceeded the per-calendar-year individual share limit under the Company's 2004 Equity Incentive Plan.
Key Financial Metrics
The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity figures. This report focuses exclusively on executive compensation adjustments and legal contingencies.
Material Changes and Actions
In response to the stockholder derivative action filed on November 24, 2014, the full Board of Directors took the following actions on December 26, 2014, to void and rescind specific equity awards granted to Dr. Su:
- Voided a performance-based restricted stock unit (RSU) award granted on October 31, 2014, covering 869,686 shares.
- Voided a performance-based RSU award granted on October 31, 2014, covering 347,874 shares.
- Voided a performance-based RSU award granted on August 12, 2014, covering 487,804 shares.
- Voided 50,000 shares of a time-based RSU award granted on October 31, 2014 (reducing the total subject to that award from 173,937 shares).
The Board determined that resolving this technicality was preferable to litigation and reaffirmed that Dr. Su's total compensation package remains appropriate and aligned with stockholder interests.
Outlook, Risks, and Contingencies
Management Commentary: The Board stated that the employment agreement terms were the result of arms-length negotiations. While voiding the awards resolves the immediate legal challenge, the Board intends to return Dr. Su's equity compensation to the level it should have been prior to the rescission at the earliest practicable opportunity, subject to law and the terms of the 2004 Plan.
Risks and Contingencies: The primary risk addressed was the stockholder derivative action in Delaware court. By voiding the awards, the Company aims to mitigate legal costs and uncertainty associated with the litigation.
Investor Verification Checklist
- Verify the specific terms of the 2004 Equity Incentive Plan regarding per-calendar-year individual share limits.
- Monitor future filings for the re-granting of equity awards to Dr. Su to restore her compensation package.
- Confirm the status of the stockholder derivative action in Delaware court to ensure it has been dismissed or settled.
- Review the Company's proxy statement for details on the Compensation Committee's approval process for Dr. Su's employment agreement.